Exercise, Cancer, and the Cardiovascular System: Clinical Effects and Mechanistic Insights

Overview

Journal Basic Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2024 Feb 14

PMID 38353711

Authors

Simon Wernhart

Tienush Rassaf

Affiliations

Soon will be listed here.

Abstract

Cardiovascular diseases and cancer are the leading causes of death in the Western world and share common risk factors. Reduced cardiorespiratory fitness (CRF) is a major determinant of cardiovascular morbidity and cancer survival. In this review we discuss cancer- induced disturbances of parenchymal, cellular, and mitochondrial function, which limit CRF and may be antagonized and attenuated through exercise training. We show the impact of CRF on cancer survival and its attenuating effects on cardiotoxicity of cancer-related treatment. Tailored exercise programs are not yet available for each tumor entity as several trials were performed in heterogeneous populations without adequate cardiopulmonary exercise testing (CPET) prior to exercise prescription and with a wide variation of exercise modalities. There is emerging evidence that exercise may be a crucial pillar in cancer treatment and a tool to mitigate cardiotoxic treatment effects. We discuss modalities of aerobic exercise and resistance training and their potential to improve CRF in cancer patients and provide an example of a periodization model for exercise training in cancer.

Citing Articles

Cardiopulmonary Functional Profiles in Cancer Therapy-Related Cardiac Dysfunction Among Patients with Non-Hodgkin Lymphoma.

Bursacovschi D, Revenco V, Robu M, Arnaut O Diagnostics (Basel). 2025; 15(4).

PMID: 40002568 PMC: 11854496. DOI: 10.3390/diagnostics15040417.

Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice.

Sayour N, Kucsera D, Alhaddad A, Toth V, Gergely T, Kovacs T Basic Res Cardiol. 2024; 120(1):207-223.

PMID: 39516409 PMC: 11790738. DOI: 10.1007/s00395-024-01088-4.

Cardioprotection of voluntary exercise against breast cancer-induced cardiac injury via STAT3.

Wu L, Li Z, Yang H, Cao L, Wang X, Wang D Basic Res Cardiol. 2024; 120(1):113-131.

PMID: 39158697 DOI: 10.1007/s00395-024-01076-8.

Cardiovascular mortality in people with cancer compared to the general population: A systematic review and meta-analysis.

Ng H, Meng R, Marin T, Damarell R, Buckley E, Selvanayagam J Cancer Med. 2024; 13(15):e70057.

PMID: 39096123 PMC: 11297437. DOI: 10.1002/cam4.70057.

Relevance of Cardiovascular Exercise in Cancer and Cancer Therapy-Related Cardiac Dysfunction.

Wernhart S, Rassaf T Curr Heart Fail Rep. 2024; 21(3):238-251.

PMID: 38696059 PMC: 11090948. DOI: 10.1007/s11897-024-00662-0.

References

Scarpulla R, Vega R, Kelly D . Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol Metab. 2012; 23(9):459-66. PMC: 3580164. DOI: 10.1016/j.tem.2012.06.006. View

Attia Z, Harmon D, Behr E, Friedman P . Application of artificial intelligence to the electrocardiogram. Eur Heart J. 2021; 42(46):4717-4730. PMC: 8500024. DOI: 10.1093/eurheartj/ehab649. View

Irrcher I, Ljubicic V, Hood D . Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am J Physiol Cell Physiol. 2008; 296(1):C116-23. DOI: 10.1152/ajpcell.00267.2007. View

Gomes Neto M, Duraes A, Conceicao L, Saquetto M, Ellingsen O, Carvalho V . High intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis. Int J Cardiol. 2018; 261:134-141. DOI: 10.1016/j.ijcard.2018.02.076. View

Hood D, Memme J, Oliveira A, Triolo M . Maintenance of Skeletal Muscle Mitochondria in Health, Exercise, and Aging. Annu Rev Physiol. 2018; 81:19-41. DOI: 10.1146/annurev-physiol-020518-114310. View

Cardaci S, Zheng L, Mackay G, van den Broek N, MacKenzie E, Nixon C . Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat Cell Biol. 2015; 17(10):1317-26. PMC: 4591470. DOI: 10.1038/ncb3233. View

Haykowsky M, Mackey J, Thompson R, Jones L, Paterson D . Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res. 2009; 15(15):4963-7. DOI: 10.1158/1078-0432.CCR-09-0628. View

Forman D, Guazzi M, Myers J, Chase P, Bensimhon D, Cahalin L . Ventilatory power: a novel index that enhances prognostic assessment of patients with heart failure. Circ Heart Fail. 2012; 5(5):621-6. PMC: 7236613. DOI: 10.1161/CIRCHEARTFAILURE.112.968529. View

Wernhart S, Papathanasiou M, Mahabadi A, Rassaf T, Luedike P . Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction. Int J Cardiol. 2022; 370:309-318. DOI: 10.1016/j.ijcard.2022.10.009. View

10.

Totzeck M, Mincu R, Mrotzek S, Schadendorf D, Rassaf T . Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: A meta-analysis of approximately 29,000 cancer patients. Eur J Prev Cardiol. 2018; 25(5):482-494. DOI: 10.1177/2047487318755193. View

11.

Mouritzen M, Carus A, Ladekarl M, Meldgaard P, Nielsen A, Livbjerg A . Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy. Cancers (Basel). 2021; 13(19). PMC: 8507718. DOI: 10.3390/cancers13194846. View

11.

You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S . Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther. 2022; 7(1):156. PMC: 9090746. DOI: 10.1038/s41392-022-00994-0. View

12.

Zong W, Rabinowitz J, White E . Mitochondria and Cancer. Mol Cell. 2016; 61(5):667-676. PMC: 4779192. DOI: 10.1016/j.molcel.2016.02.011. View

13.

Tarkin J, Joshi F, Evans N, Chowdhury M, Figg N, Shah A . Detection of Atherosclerotic Inflammation by Ga-DOTATATE PET Compared to [F]FDG PET Imaging. J Am Coll Cardiol. 2017; 69(14):1774-1791. PMC: 5381358. DOI: 10.1016/j.jacc.2017.01.060. View

13.

Totzeck M, Schuler M, Stuschke M, Heusch G, Rassaf T . Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol. 2019; 280:163-175. DOI: 10.1016/j.ijcard.2019.01.038. View

14.

Karsli-Uzunbas G, Guo J, Price S, Teng X, Laddha S, Khor S . Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 2014; 4(8):914-27. PMC: 4125614. DOI: 10.1158/2159-8290.CD-14-0363. View

15.

Hansen J, Sue D, Wasserman K . Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984; 129(2 Pt 2):S49-55. DOI: 10.1164/arrd.1984.129.2P2.S49. View

16.

Jones L, Fels D, West M, Allen J, Broadwater G, Barry W . Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila). 2013; 6(9):925-37. PMC: 3800005. DOI: 10.1158/1940-6207.CAPR-12-0416. View

17.

Mincu R, Mahabadi A, Michel L, Mrotzek S, Schadendorf D, Rassaf T . Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis. JAMA Netw Open. 2019; 2(8):e198890. PMC: 6692687. DOI: 10.1001/jamanetworkopen.2019.8890. View

18.

Totzeck M, Aide N, Bauersachs J, Bucerius J, Georgoulias P, Herrmann K . Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging. 2022; 50(3):792-812. PMC: 9852191. DOI: 10.1007/s00259-022-05991-7. View